Lose fifty pounds quickly and the skin does not always follow. Some people mind and some do not. The ones who mind and can afford to act on it end up in a surgeon’s office, and that visit is not in anybody’s price comparison — not even in the careful version of the arithmetic.
What was counted, and what was not
Researchers took a large health-records database, identified people who had aesthetic procedures between 2016 and 2024, and split them by whether they had previously had bariatric surgery or used a GLP-1. [1] Between 2016 and 2021, the mean annual growth rate of procedures among GLP-1 users was 36.1% a year against 27.1% among post-bariatric patients, P=.0026. After 2021, GLP-1 users rose to 53.8% a year, +17.7% with a 95% CI of 10.4% to 25.4%, while the post-bariatric group fell to −4%, a change of −31.1% with a 95% CI of −37.7% to −25.5%.
The complication finding favors the drug
After propensity matching, the post-bariatric patients had the worse surgical course. Hematoma came in at RR 1.99, 95% CI 1.10 to 3.62. Infection at RR 1.37, 95% CI 1.01 to 1.88. Emergency department use at RR 1.54, 95% CI 1.05 to 2.26. All at P < .05.
That is a real point in favor of the drug route and it should be read with the usual discount. These are two very different populations — one had major abdominal surgery and a different weight trajectory — and matching on recorded variables does not make them comparable. The authors call for work on the underlying factors, which is the right request.
Why this belongs on a price page
Because body contouring is cash. Insurance covers it rarely and narrowly, usually only where skin causes documented medical problems. A cosmetic procedure after weight loss is paid the way the drug is paid: out of pocket, by the person who bought the drug.
That does not make it a hidden cost of the prescription, and it would be dishonest to frame it as one. Most people will not have surgery. But the monthly figure on a product page is presented as the cost of the outcome, and it is not — it is the cost of the drug. The other things a year of rapid weight loss can lead to belong in the same ledger as everything else nobody itemizes.
What to take from it
Not a reason to avoid the drug, and not a reason to plan surgery. Two narrower things. First, loose skin is a known consequence of fast weight loss and no seller on this roster mentions it, in the same way nobody mentions what happens when you stop. Second, if it matters to you, slower loss and attention to lean mass are the levers that exist, and both are decisions made at the start rather than at the end.
Price the drug against what you want from it, not against the best case. The six-month view is the honest starting point, and it is still only the drug.